IL145635A0 - Taxane formulations having improved solubility - Google Patents

Taxane formulations having improved solubility

Info

Publication number
IL145635A0
IL145635A0 IL14563501A IL14563501A IL145635A0 IL 145635 A0 IL145635 A0 IL 145635A0 IL 14563501 A IL14563501 A IL 14563501A IL 14563501 A IL14563501 A IL 14563501A IL 145635 A0 IL145635 A0 IL 145635A0
Authority
IL
Israel
Prior art keywords
improved solubility
taxane formulations
taxane
formulations
solubility
Prior art date
Application number
IL14563501A
Other languages
English (en)
Original Assignee
Univ Florida State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Florida State Res Found filed Critical Univ Florida State Res Found
Publication of IL145635A0 publication Critical patent/IL145635A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D407/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL14563501A 2000-02-02 2001-02-02 Taxane formulations having improved solubility IL145635A0 (en)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US17978200P 2000-02-02 2000-02-02
US17967100P 2000-02-02 2000-02-02
US17968400P 2000-02-02 2000-02-02
US17967200P 2000-02-02 2000-02-02
US17967400P 2000-02-02 2000-02-02
US17979300P 2000-02-02 2000-02-02
US17967000P 2000-02-02 2000-02-02
US17966900P 2000-02-02 2000-02-02
PCT/US2001/003624 WO2001057013A1 (en) 2000-02-02 2001-02-02 Taxane formulations having improved solubility

Publications (1)

Publication Number Publication Date
IL145635A0 true IL145635A0 (en) 2002-06-30

Family

ID=27575082

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14563501A IL145635A0 (en) 2000-02-02 2001-02-02 Taxane formulations having improved solubility

Country Status (9)

Country Link
EP (1) EP1175414A1 (xx)
KR (1) KR20010111580A (xx)
AU (1) AU3481001A (xx)
BR (1) BR0104358A (xx)
HU (1) HUP0200995A3 (xx)
IL (1) IL145635A0 (xx)
NO (1) NO20014752L (xx)
NZ (1) NZ514073A (xx)
WO (1) WO2001057013A1 (xx)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6649632B2 (en) 2000-02-02 2003-11-18 Fsu Research Foundation, Inc. C10 ester substituted taxanes
CA2368534A1 (en) 2000-02-02 2001-08-09 Florida State University Research Foundation, Inc. C7 heterosubstituted acetate taxanes as antitumor agents
CO5280224A1 (es) 2000-02-02 2003-05-30 Univ Florida State Res Found Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen
TR200102855T1 (tr) 2000-02-02 2002-06-21 Florida State University Research Foundation, Inc Antitümör ajanları olarak C10 karbonat ikameli taksanlar.
RU2265019C2 (ru) 2000-02-02 2005-11-27 Флорида Стейт Юниверсити Рисерч Фаундейшн, Инк. Таксаны, фармацевтические композиции, способы ингибирования
CN1362876A (zh) 2000-02-02 2002-08-07 佛罗里达州立大学研究基金有限公司 C10杂取代的乙酸基紫衫烷抗肿瘤剂
NZ514407A (en) 2000-02-02 2004-12-24 Univ Florida State Res Found C10 carbamoyloxy substituted taxanes as antitumor agents
CA2354478A1 (en) * 2001-07-31 2003-01-31 Florida State University Research Foundation, Inc. C10 carbonate substituted taxanes
CA2354486A1 (en) * 2001-07-31 2003-01-31 Florida State University Research Foundation, Inc. C7 ester substituted taxanes
WO2004013093A2 (en) 2002-08-02 2004-02-12 Immunogen, Inc. Cytotoxic agents containing novel potent taxanes and their therapeutic use
US7390898B2 (en) 2002-08-02 2008-06-24 Immunogen Inc. Cytotoxic agents containing novel potent taxanes and their therapeutic use
SV2006002010A (es) 2004-02-13 2006-08-23 Univ Florida State Res Found Taxanos sustituidos con esteres de ciclopentilo en c10
GT200500041A (es) 2004-03-05 2005-10-24 Taxanos con sustituyente lactiloxilo en el c7
EP2276755A4 (en) * 2008-03-31 2011-05-04 Univ Florida State Res Found C (10) -ETHYESTER- AND C (10) -CYCLOPROPYLESTER-SUBSTITUTED TAXANES

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250683A (en) * 1991-09-23 1993-10-05 Florida State University Certain substituted taxanes and pharmaceutical compositions containing them
US5243045A (en) * 1991-09-23 1993-09-07 Florida State University Certain alkoxy substituted taxanes and pharmaceutical compositions containing them
IL107950A (en) * 1992-12-15 2001-04-30 Upjohn Co b 7, b 8 - Matano - Taxols, their preparation and pharmaceutical preparations against malignant tumors containing them
CA2174350A1 (en) * 1993-10-20 1995-04-27 Richard B. Greenwald 2'- and/or 7- substituted taxoids
JPH10508022A (ja) * 1994-10-28 1998-08-04 ザ リサーチ ファウンデーション オブ ステート ユニバーシティ オブ ニューヨーク タキソイド誘導体、それらの製造、およびそれらの抗腫瘍薬としての使用
US6100411A (en) * 1994-10-28 2000-08-08 The Research Foundation Of State University Of New York Taxoid anti-tumor agents and pharmaceutical compositions thereof
US5801191A (en) * 1995-06-01 1998-09-01 Biophysica Foundation Taxoids
KR100476247B1 (ko) * 1996-07-15 2005-03-10 가부시키가이샤 야쿠루트 혼샤 탁산 유도체 및 그를 함유하는 의약
JPH1192468A (ja) * 1997-09-17 1999-04-06 Yakult Honsha Co Ltd 新規なタキサン誘導体
WO1999032473A1 (fr) * 1997-12-19 1999-07-01 Kabushiki Kaisha Yakult Honsha Derives de taxane
JP2003026673A (ja) * 1999-03-05 2003-01-29 Asahi Kasei Corp 骨形成促進剤

Also Published As

Publication number Publication date
HUP0200995A3 (en) 2005-02-28
HUP0200995A2 (hu) 2002-07-29
NZ514073A (en) 2004-02-27
EP1175414A1 (en) 2002-01-30
NO20014752L (no) 2001-11-27
KR20010111580A (ko) 2001-12-19
BR0104358A (pt) 2002-01-02
WO2001057013A1 (en) 2001-08-09
AU3481001A (en) 2001-08-14
NO20014752D0 (no) 2001-10-01

Similar Documents

Publication Publication Date Title
HUP0301413A3 (en) Vaccine compositions
HUP0302117A3 (en) Vaccine composition
GB0001621D0 (en) Pharmaceutical compositions
GB0020089D0 (en) Vaccine Composition
AU6219601A (en) Pharmaceutical compositions
PL350075A1 (en) Taxane formulations having improved solubility
GB0009584D0 (en) Pharmaceutical compositions
GB0019232D0 (en) Antiperspirant formulations
EP1320385A4 (en) COMBINATION COMPOSITIONS
AU8576801A (en) Pharmaceutical compositions
HUP0200995A3 (en) Taxane formulations having improved solubility
GB0015490D0 (en) Novel formulations
AU1390002A (en) Pharmaceutical compositions
GB0019651D0 (en) Compositions
GB0008485D0 (en) Pharmaceutical compositions
GB0019230D0 (en) Antiperspirant formulations
GB0009613D0 (en) Pharmaceutical compositions
GB0009607D0 (en) Medical compositions
HK1061978A1 (en) Lipid peroxide-lowering compositions
HUP0600589A2 (en) Adjuvant combination formulations
GB0004518D0 (en) Compositions
HK1047933A1 (zh) 具有改善的溶解度的紫杉烷製劑
AU8254101A (en) Medicinal compositions
GB0004522D0 (en) Compositions
GB0022027D0 (en) Disfectant formulations